Standout Papers

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 2020 2026 2022 2024321
  1. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 (2020)
    Eric J. Lenze, Caline Mattar et al. JAMA

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
2025 Standout
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
2 intermediate papers

Works of Eric J. Lenze being referenced

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
2021
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study
2007

Author Peers

Author Last Decade Papers Cites
Eric J. Lenze 3273 1957 2633 2726 342 11.4k
Gábor S. Ungvári 2728 1782 4720 3768 550 13.2k
Erik J. Giltay 2515 1100 2072 3545 374 16.1k
Martin Preisig 2364 758 2479 2971 281 13.2k
Hannie C. Comijs 1824 899 3882 2433 290 11.4k
Aart H. Schene 2643 2019 4480 4377 328 15.4k
Kay Wilhelm 1779 1569 2442 3749 238 10.2k
Sati Mazumdar 2168 1860 2624 1791 151 8.1k
Wolfgang Maier 3263 1334 5190 3084 457 18.2k
Meryl A. Butters 2414 2189 5494 1699 252 12.5k
Murray A. Raskind 1844 2845 5033 2336 275 22.1k

All Works

Loading papers...

Rankless by CCL
2026